SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (10701)7/10/1999 3:02:00 PM
From: Robert K.  Respond to of 17367
 
Two points.
1. looks like biogen has to square away manufactoring stuff, and yes there are other psoriasis drugs out there. However hu1124 looks quite good as a "selective" t-cell modulator.
2. Which brings me to my second point, about "other" possible uses
for a selective t-cell drug. I personally expect it. Whether or not it happens we will see.

Bluegreen>may not be off the mark. (or may be) more latter.
Standard K.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News